Korea BNC Obtains Chinese Patent for Dexibuprofen Liquid Injection
Predicted impact: Low· Actual: −5.5% vs sector, volume 0.2× normal (5 trading days)
Chinese patent registration for an injectable drug; small, routine and no revenue size given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.